Anantha Shekhar, M.D., Ph.D., is the executive associate dean for research affairs, overseeing all research-related activities, at the Indiana University (IU) School of Medicine and the director of the Indiana Clinical and Translational Sciences Institute (Indiana CTSI). In addition to his IU School of Medicine and Indiana CTSI roles, Shekhar serves as associate vice president for university clinical affairs for IU and executive vice president of academic affairs for clinical research at IU Health. In addition to his role in leading the statewide translational research initiative, Shekhar leads successful basic and clinical research programs in the areas of stress, anxiety and neuropsychiatric disorders. His laboratory has developed some of the best translational models for panic and related anxiety disorders. His work focuses on the role of brain abnormalities that could lead to stress and psychiatric disorders and has more recently extended these studies to the discovery of new treatments. A number of grants from the National Institutes of Health, private foundations and commercial collaborations currently support his research.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- About NCATS
- Advisory Groups
- NCATS Advisory Council
- Council Roster
- Anantha Shekhar, M.D., Ph.D. (2018)
Anantha Shekhar, M.D., Ph.D. (2018)
- Funding & Notices
-